These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 1997166

  • 1. Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells.
    Brockhausen I, Kuhns W, Schachter H, Matta KL, Sutherland DR, Baker MA.
    Cancer Res; 1991 Feb 15; 51(4):1257-63. PubMed ID: 1997166
    [Abstract] [Full Text] [Related]

  • 2. Glycosyltransferase changes upon differentiation of CaCo-2 human colonic adenocarcinoma cells.
    Brockhausen I, Romero PA, Herscovics A.
    Cancer Res; 1991 Jun 15; 51(12):3136-42. PubMed ID: 1904002
    [Abstract] [Full Text] [Related]

  • 3. Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
    Kuhns W, Rutz V, Paulsen H, Matta KL, Baker MA, Barner M, Granovsky M, Brockhausen I.
    Glycoconj J; 1993 Oct 15; 10(5):381-94. PubMed ID: 8298305
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the specificities of human blood group H gene-specified alpha 1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: evidence for an inverse relationship between alpha 1,2-L-fucosylation of Gal and alpha 1,6-L-fucosylation of asparagine-linked GlcNAc.
    Chandrasekaran EV, Jain RK, Larsen RD, Wlasichuk K, Matta KL.
    Biochemistry; 1996 Jul 09; 35(27):8914-24. PubMed ID: 8688427
    [Abstract] [Full Text] [Related]

  • 5. The biosynthesis of branched O-glycans.
    Schachter H, Brockhausen I.
    Symp Soc Exp Biol; 1989 Jul 09; 43():1-26. PubMed ID: 2701469
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis.
    Yousefi S, Higgins E, Daoling Z, Pollex-Krüger A, Hindsgaul O, Dennis JW.
    J Biol Chem; 1991 Jan 25; 266(3):1772-82. PubMed ID: 1824844
    [Abstract] [Full Text] [Related]

  • 8. Control of O-glycan synthesis: specificity and inhibition of O-glycan core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 3-galactosyltransferase from rat liver.
    Brockhausen I, Möller G, Pollex-Krüger A, Rutz V, Paulsen H, Matta KL.
    Biochem Cell Biol; 1992 Feb 25; 70(2):99-108. PubMed ID: 1510830
    [Abstract] [Full Text] [Related]

  • 9. [Primary structure of the glycan chains of normal C 1 esterase inhibitor (C 1-INH) after NMR analysis at 400 MHz].
    Strecker G, Ollier-Hartmann MP, van Halbeek H, Vliegenthart JF, Montreuil J, Hartmann L.
    C R Acad Sci III; 1985 Feb 25; 301(11):571-6. PubMed ID: 3936597
    [Abstract] [Full Text] [Related]

  • 10. A fluorescent assay for the determination of UDP-GlcNAc: Gal beta 1,3GalNAc-R (GlcNAc to GalNAc) beta 1,6-N-acetylglucosaminyltransferase activity.
    Palmerini CA, Datti A, Alunni S, VanderElst IE, Orlacchio A.
    Anal Biochem; 1995 Mar 01; 225(2):315-20. PubMed ID: 7762797
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.
    Thurnher M, Clausen H, Fierz W, Lanzavecchia A, Berger EG.
    Eur J Immunol; 1992 Jul 01; 22(7):1835-42. PubMed ID: 1378020
    [Abstract] [Full Text] [Related]

  • 13. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer.
    Vavasseur F, Dole K, Yang J, Matta KL, Myerscough N, Corfield A, Paraskeva C, Brockhausen I.
    Eur J Biochem; 1994 Jun 01; 222(2):415-24. PubMed ID: 8020479
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Unbranched polylactosamino-O-glycans on human skim milk mucins exhibit Gal beta(1-4)GlcNAc beta(1-6) repeating units.
    Hanisch FG, Uhlenbruck G, Peter-Katalinic J, Egge H, Dabrowski U, Dabrowski J.
    Symp Soc Exp Biol; 1989 Jun 01; 43():155-62. PubMed ID: 2701475
    [Abstract] [Full Text] [Related]

  • 18. Tn antigen and UDP-Gal:GalNAc alpha-R beta 1-3Galactosyltransferase expression in human breast carcinoma.
    Zhuang D, Yousefi S, Dennis JW.
    Cancer Biochem Biophys; 1991 Nov 01; 12(3):185-98. PubMed ID: 1844911
    [Abstract] [Full Text] [Related]

  • 19. [Glycosyltransferase genes as tumor marker].
    Nakayama J, Shimizu F, Katsuyama T.
    Rinsho Byori; 2002 Nov 01; Suppl 123():142-8. PubMed ID: 12652802
    [Abstract] [Full Text] [Related]

  • 20. Mucin synthesis. Conversion of R1-beta 1-3Gal-R2 to R1-beta 1-3(GlcNAc beta 1-6)Gal-R2 and of R1-beta 1-3GalNAc-R2 to R1-beta 1-3(GlcNAc beta 1-6)GalNAc-R2 by a beta 6-N-acetylglucosaminyltransferase in pig gastric mucosa.
    Brockhausen I, Matta KL, Orr J, Schachter H, Koenderman AH, van den Eijnden DH.
    Eur J Biochem; 1986 Jun 16; 157(3):463-74. PubMed ID: 2941299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.